⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘Chronic monocytic leukemia✘Neuroleukosis
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 100%(13)37%(2)
Blood biochemistry 58%(2)—
CT of the organ —44%(0)
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 100%—
Register, to see more distinctive signs of diseases and studies —100%
chronic monocytic leukemia 92% —
meningeal symptoms — 72%
monocytosis 57% —
meningeal syndrome — 67%
professional cancer 48% —
increased intracranial pressure — 61%
lowered 62% 21%
radiation damage — 57%
thrombocytopenia 36% —
concomitant strabismus — 56%
erythrocytic anemia 34% —
meningoencephalitis — 55%
waldenstrom 's macroglobulinemia 34% —
neurological disorders — 54%
chronic leukemia 33% —
lymphocytic — 54%
chronic myeloid leukemia 31% —
hemiparesis — 52%
increased gamma globulins 29% —
damage to the nervous system — 52%
hemorrhagic syndrome 26% —
postencephalitic syndrome — 51%
subacute condition 26% —
convulsions — 51%
more often in old age 23% —
tumors of peripheral nerves — 50%
anemia 22% —
polyneuropathy — 50%
very correct 22% —
oncology — 49%
chronic anemia 22% —
impaired venous function — 49%
increased ESR 22% —
occlusive hydrocephalus — 49%
tuberculosis 20% —
hemiparetic gait — 48%
high temperature 18% —
spasm in the back of the head — 48%
feeling of heat 18% —
facial asymmetry — 47%
acute leukemia 61% 52%
brain tumor — 47%
leukoencephalitis — 47%
jackson 's epilepsy — 46%
radiation therapy — 46%
neuroinfections — 45%
leukemia in children — 45%
leukemia 26% 70%
headache photophobia — 44%
headaches — 43%
motor aphasia — 43%
tibial nerve neuropathy — 43%
acute lymphoblastic leukemia — 42%
epilepsy attacks — 41%
periodic illness — 40%
rigidity of the occipital muscles — 40%
speech slurred — 39%
asymmetry — 39%
epilepsy — 39%
sensory aphasia — 39%
paresis — 38%
vascular tumor — 37%
skin anesthesia — 37%
ptosis of the upper eyelids — 37%
cramps in the extremities — 37%
weak ligaments — 36%
facial crevices — 36%
history of surgery — 36%
whole head hurts — 35%
vomiting — 35%
weakness after illness — 35%
anesthesia — 35%
weakness of the ligaments — 34%
hyperkinesis — 33%
shroud — 33%
aphasia — 33%
porous skin — 32%
headache to vomiting — 32%
cancer 21% 53%
increased blood clotting — 32%
inhibition — 32%
double vision — 32%
strabismus — 32%
photophobia — 31%
hydrocephalus — 31%
weakness in the extremities — 31%
meningitis — 30%
cramps in the legs — 30%
severe headache neck pain — 30%
muscle hypertonus — 29%
tingling — 29%
full — 29%
brain tumors — 29%
muscle tension — 29%
s eyes cloudy — 29%
osteoporosis — 28%
hearing impaired — 28%
impaired nervous system function — 28%
stiffness in the joints — 27%
hemorrhagic diathesis — 27%
general weakness — 27%
spasm — 26%
muscle weakness — 26%
attacks of pain — 24%
acute pain — 24%
there are no complaints — 23%
swelling — 23%
drug disease — 23%
consequences of infection — 23%
onset of illness — 23%
patient's condition — 22%
consequences of taking medications — 22%
blood diseases 33% 50%
leukocytosis 20% 37%
metastases 23% 39%
hepatosplenomegaly 23% 32%
enlargement of the spleen 22% 30%
enlargement of the liver and spleen 23% 31%
enlarged liver 20% 27%
childhood diseases 17% 23%

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.